- Home
- MLKN vs MNKD Comparison
MLKN vs MNKD Comparison
Compare MLKN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- MNKD
- Stock Information
- Founded
- MLKN 1905
- MNKD 1991
- Country
- MLKN United States
- MNKD United States
- Employees
- MLKN N/A
- MNKD N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- MNKD Health Care
- Exchange
- MLKN Nasdaq
- MNKD Nasdaq
- Market Cap
- MLKN 1.2B
- MNKD 1.2B
- IPO Year
- MLKN N/A
- MNKD 2004
- Fundamental
- Price
- MLKN $21.44
- MNKD $5.54
- Analyst Decision
- MLKN
- MNKD Buy
- Analyst Count
- MLKN 0
- MNKD 6
- Target Price
- MLKN N/A
- MNKD $10.33
- AVG Volume (30 Days)
- MLKN 366.3K
- MNKD 5.3M
- Earning Date
- MLKN 09-23-2025
- MNKD 08-06-2025
- Dividend Yield
- MLKN 3.54%
- MNKD N/A
- EPS Growth
- MLKN N/A
- MNKD 149.32
- EPS
- MLKN N/A
- MNKD 0.11
- Revenue
- MLKN $3,669,900,000.00
- MNKD $301,736,000.00
- Revenue This Year
- MLKN $4.74
- MNKD $14.52
- Revenue Next Year
- MLKN $3.64
- MNKD $12.81
- P/E Ratio
- MLKN N/A
- MNKD $50.97
- Revenue Growth
- MLKN 1.14
- MNKD 21.48
- 52 Week Low
- MLKN $15.25
- MNKD $3.38
- 52 Week High
- MLKN $28.69
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- MLKN 56.83
- MNKD 72.22
- Support Level
- MLKN $20.37
- MNKD $5.22
- Resistance Level
- MLKN $21.76
- MNKD $6.20
- Average True Range (ATR)
- MLKN 0.60
- MNKD 0.26
- MACD
- MLKN -0.09
- MNKD 0.18
- Stochastic Oscillator
- MLKN 57.53
- MNKD 73.17
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.